The Indian journal of tuberculosis · 2026
A novel Three-miRNA diagnostic signature for tuberculosis: Non-invasive detection and stratification from latent to active disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tulab Abdulrahman M, Abdullah Essam Mohammed, Eyada Haitham N
Аннотация
BACKGROUND: Tuberculosis (TB) is the leading infectious killer and about a quarter of the world's population is estimated to have latent TB infection (LTBI). Present diagnostics do not convincingly separate latent from active TB cases; thus, there is an urgent need for new biomarkers to facilitate accurate diagnosis and risk stratification.
OBJECTIVES: This study seeks the development and validation of a three-microRNA signature consisting of miR-29a, miR-144, and miR-199a in the diagnosis and risk stratification of tuberculosis (TB), gradients of expression across the spectrum be established cut-off values that would work optimally to assist clinical decision-making.
MATERIALS AND METHODS: A cross-sectional study was carried out on 100 participants comprising 30 healthy controls (HC), 35 with latent tuberculosis infection (LTBI), and 35 patients suffering from active TB. Quantification of microRNA expression levels was done using real-time polymerase chain reaction (PCR). The diagnostic accuracy of this microRNA signature was determined through ROC curve analysis. The applied statistical methods were ANOVA, post hoc testing, and correlation analysis.
RESULTS: The three-microRNA signature showed graded expression across the spectrum of TB. MiR-29a revealed maximum differences in expression levels between groups (HC: 1.200 ± 0.485, LTBI: 2.644 ± 1.729, Active TB: 7.380 ± 6.138; p < 0.001). MiR-144 and miR-199a have followed a similar pattern of expression. The combined microRNA signature has excellent diagnostic accuracy with an area under the curve (AUC) of 0.92 for the separation of active TB from LTBI, and good performance yielding an AUC of 0.84 when distinguishing LTBI from healthy control.
CONCLUSION: The three-microRNA signature represents a promising non-invasive blood-based approach for differentiating healthy controls, LTBI, and active TB in this single-center cross-sectional study. The observed expression gradients and diagnostic performance support further evaluation in larger, independent, multi-center cohorts.
OBJECTIVES: This study seeks the development and validation of a three-microRNA signature consisting of miR-29a, miR-144, and miR-199a in the diagnosis and risk stratification of tuberculosis (TB), gradients of expression across the spectrum be established cut-off values that would work optimally to assist clinical decision-making.
MATERIALS AND METHODS: A cross-sectional study was carried out on 100 participants comprising 30 healthy controls (HC), 35 with latent tuberculosis infection (LTBI), and 35 patients suffering from active TB. Quantification of microRNA expression levels was done using real-time polymerase chain reaction (PCR). The diagnostic accuracy of this microRNA signature was determined through ROC curve analysis. The applied statistical methods were ANOVA, post hoc testing, and correlation analysis.
RESULTS: The three-microRNA signature showed graded expression across the spectrum of TB. MiR-29a revealed maximum differences in expression levels between groups (HC: 1.200 ± 0.485, LTBI: 2.644 ± 1.729, Active TB: 7.380 ± 6.138; p < 0.001). MiR-144 and miR-199a have followed a similar pattern of expression. The combined microRNA signature has excellent diagnostic accuracy with an area under the curve (AUC) of 0.92 for the separation of active TB from LTBI, and good performance yielding an AUC of 0.84 when distinguishing LTBI from healthy control.
CONCLUSION: The three-microRNA signature represents a promising non-invasive blood-based approach for differentiating healthy controls, LTBI, and active TB in this single-center cross-sectional study. The observed expression gradients and diagnostic performance support further evaluation in larger, independent, multi-center cohorts.